{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:47:52Z","timestamp":1785883672546,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41440-026-02714-5","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:11:06Z","timestamp":1781856666000},"page":"2301-2306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recent developments and challenges in hypertensive dementia over the past year"],"prefix":"10.1038","volume":"49","author":[{"given":"Masaki","family":"Mogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hoshide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"2714_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.125.26572","volume":"83","author":"B Wang","year":"2026","unstructured":"Wang B, Sun Y, Li Y, Wu L, Peng Y, Li S, et al. Intensive BP control and cognitive function: a randomized clinical trial. Hypertension. 2026;83:e26572.","journal-title":"Hypertension"},{"key":"2714_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1161\/STROKEAHA.125.051564","volume":"57","author":"Y Li","year":"2026","unstructured":"Li Y, Li C. Antihypertensive medication adherence, APOE genotype, and subsequent dementia in community-dwelling adults \u226550 years. Stroke. 2026;57:597\u2013610.","journal-title":"Stroke"},{"key":"2714_CR3","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.70784","volume":"14","author":"JF Bangle","year":"2026","unstructured":"Bangle JF, Jennings WE, Guadagni AJ, Albino GR, Grundstein AJ, Wolf ST. Cutaneous microvascular function is reduced in winter compared with summer in healthy young adults. Physiol Rep. 2026;14:e70784.","journal-title":"Physiol Rep"},{"key":"2714_CR4","doi-asserted-by":"crossref","unstructured":"Duin JJ, Trompet S, Giltay E, Johnson JT, Gussekloo J, Poortvliet R, et al. Temporal dynamics of blood pressure, functional status and cognitive function in adults aged 85 years and older: a dynamic time warping approach in the Leiden 85-plus study. Age Ageing. 2026;55:afag006.","DOI":"10.1093\/ageing\/afag006"},{"key":"2714_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70739","volume":"21","author":"A Sood","year":"2025","unstructured":"Sood A, Capuano AW, Mehta R, Barnes LL, Bennett DA, Arvanitakis Z. Relationship of antihypertensives with late-life cognitive decline and neuropathology. Alzheimer's Dement. 2025;21:e70739.","journal-title":"Alzheimer's Dement"},{"key":"2714_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2026.106185","volume":"27","author":"L Ding","year":"2026","unstructured":"Ding L, Zhang M, Wu H, Wang X, Zhu X, Chen Z, et al. Impact of different antihypertensive drug classes on incident dementia in older adults: a systematic review and meta-analysis. J Am Med Dir Assoc. 2026;27:106185.","journal-title":"J Am Med Dir Assoc"},{"key":"2714_CR7","doi-asserted-by":"publisher","unstructured":"Amare F, Mirkazemi C, Peterson GM, Bezabhe WM. Clinical outcomes of antihypertensive medication use in people with dementia: a systematic review and meta-analysis. Geroscience. 2025. https:\/\/doi.org\/10.1007\/s11357-025-01957-3.","DOI":"10.1007\/s11357-025-01957-3"},{"key":"2714_CR8","doi-asserted-by":"crossref","unstructured":"Huang S, Lai W, Zhao Y, Pan K, Xu H, Lin S, et al. Hypertension, Antihypertensive treatment, and memory decline: consistent and divergent patterns in aging populations across four countries, 2010\u20139. Am J Prev Med. 2026;71:108343.","DOI":"10.1016\/j.amepre.2026.108343"},{"key":"2714_CR9","volume":"17","author":"MH Khan","year":"2025","unstructured":"Khan MH, Pathan S, Ansari K, Baig S, Ghafoor A, Minhas M, et al. Comparative risk assessment in hypertensive patients with metabolic syndrome by exploring angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers. Cureus. 2025;17:e85564.","journal-title":"Cureus"},{"key":"2714_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/alz.71153","volume":"22","author":"CH Liu","year":"2026","unstructured":"Liu CH, Tsai ML, Yang NI, Chang TY, Chen TH, Wei YC. Risks of dementia and stroke in patients with hypertension using telmisartan or other renin\u2011angiotensin system inhibitors. Alzheimer's Dement. 2026;22:e71153.","journal-title":"Alzheimer's Dement"},{"key":"2714_CR11","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1007\/s11357-024-01409-4","volume":"47","author":"KM Nist","year":"2025","unstructured":"Nist KM, Bard H, McBride B, Capriglione AL, Moreira JD, Farb DH, et al. Losartan attenuates sex-dependent hypertension, neuroinflammation, and cognitive impairment in the aging male Sprague-Dawley rat. Geroscience. 2025;47:3007\u201326.","journal-title":"Geroscience"},{"key":"2714_CR12","doi-asserted-by":"publisher","first-page":"e2559113","DOI":"10.1001\/jamanetworkopen.2025.59113","volume":"9","author":"SL Gray","year":"2026","unstructured":"Gray SL, Yu O, Gatto NM, Marcum ZA, Latimer CS, Postupna N, et al. Angiotensin II-stimulating antihypertensive medications and dementia-related neuropathology. JAMA Netw Open. 2026;9:e2559113.","journal-title":"JAMA Netw Open"},{"key":"2714_CR13","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1007\/s11357-025-01600-1","volume":"47","author":"EA Belachew","year":"2025","unstructured":"Belachew EA, Peterson GM, Bezabhe WM. Comparative effects of angiotensin II stimulating and inhibiting antihypertensives on dementia risk: a systematic review and meta-analysis. Geroscience. 2025;47:5525\u201341.","journal-title":"Geroscience"},{"key":"2714_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/HYPERTENSIONAHA.123.19943","volume":"81","author":"AH Hainsworth","year":"2024","unstructured":"Hainsworth AH, Markus HS, Schneider JA. Cerebral small vessel disease, hypertension, and vascular contributions to cognitive impairment and dementia. Hypertension. 2024;81:75\u201386.","journal-title":"Hypertension"},{"key":"2714_CR15","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1161\/HYPERTENSIONAHA.125.25202","volume":"82","author":"JJ Pruzin","year":"2025","unstructured":"Pruzin JJ, Yau WW, Bress AP, Bardaran H, Chhatwal JP, Tariot PN, et al. Effect of intensive systolic blood pressure control on markers of cerebral small vessel disease by age. Hypertension. 2025;82:2150\u201361.","journal-title":"Hypertension"},{"key":"2714_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.124.011902","volume":"18","author":"R Yang","year":"2025","unstructured":"Yang R, Fang Z, Yang D, Zhang L, Yang Q, Ling Q, et al. Diastolic blood pressure and cognitive function in adults with achieved systolic blood pressure below 130 mm Hg: insights from the SPRINT-MIND trial. Circ Cardiovasc Qual Outcomes. 2025;18:e011902.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2714_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213334","volume":"104","author":"DM Reboussin","year":"2025","unstructured":"Reboussin DM, Gaussoin SA, Pajewski NM, Jaeger BC, Sachs B, Rapp SR, et al. Long-term effect of intensive vs standard blood pressure control on mild cognitive impairment and probable dementia in SPRINT. Neurology. 2025;104:e213334.","journal-title":"Neurology"},{"key":"2714_CR18","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1097\/HJH.0000000000004093","volume":"43","author":"M Reddy","year":"2025","unstructured":"Reddy M, Li J, Pajewski NM, Gaussoin SA, Bryan RN, Nasrallah IM, et al. Cerebral small vessel disease and effects of intensive versus standard blood pressure treatment on cardiovascular outcomes and adverse events. J Hypertens. 2025;43:1582\u201388.","journal-title":"J Hypertens"},{"key":"2714_CR19","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/13872877241303378","volume":"103","author":"IJ Sible","year":"2025","unstructured":"Sible IJ, Nation DA. Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial. J Alzheimers Dis. 2025;103:396\u2013405.","journal-title":"J Alzheimers Dis"},{"key":"2714_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/HYPERTENSIONAHA.124.24222","volume":"82","author":"W Zhang","year":"2025","unstructured":"Zhang W, Redline S, Viswanathan A, Ascher SB, Hari D, Juraschek SP, et al. Hypotensive episodes on 24-hour ambulatory blood pressure and cognitive function: insights from the SPRINT study. Hypertension. 2025;82:627\u201337.","journal-title":"Hypertension"},{"key":"2714_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/ajh\/hpaf188","volume":"39","author":"T Sproule","year":"2026","unstructured":"Sproule T, Sargent L, Price E, Mackiewicz M, Thacker L, Dixon D. Association between ABPM phenotypes and cognitive impairment in a community-dwelling, older adult population taking antihypertensive medication: a pilot study. Am J Hypertens. 2026;39:367\u201371.","journal-title":"Am J Hypertens"},{"key":"2714_CR22","doi-asserted-by":"publisher","unstructured":"Dintica CS, Jiang X, Shaw LM, Bryan RN, Yaffe K. Cardiovascular health at midlife and Alzheimer's disease biomarkers. 2026.04.15.26350968. Preprint at https:\/\/doi.org\/10.64898\/2026.04.15.26350968.","DOI":"10.64898\/2026.04.15.26350968"},{"key":"2714_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000214935","volume":"106","author":"M Gibson","year":"2026","unstructured":"Gibson M, Snelson M, Rowsthorn E, Cribb L, Franks K, Mangan C, et al. Association of 24-hour blood pressure variability with cognition and brain MRI markers of structural change in adults in mid- to late-life. Neurology. 2026;106:e214935.","journal-title":"Neurology"},{"key":"2714_CR24","doi-asserted-by":"publisher","unstructured":"Gibson M, O\u2019Brien WT, Rowsthorn E, Franks KH, Cribb L, Cavuoto M, et al. Twenty-four-hour blood pressure and CSF biomarkers of Alzheimer\u2019s disease and related dementias in a community cohort. Geroscience. 2026. https:\/\/doi.org\/10.1007\/s11357-026-02220-z.","DOI":"10.1007\/s11357-026-02220-z"},{"key":"2714_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jacc.2015.12.034","volume":"67","author":"LH Kuller","year":"2016","unstructured":"Kuller LH, Lopez OL, Mackey RH, Rosano C, Edmundowicz D, Becker JT, et al. Subclinical cardiovascular disease and death, dementia, and coronary heart disease in patients 80+ years. J Am Coll Cardiol. 2016;67:1013\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"2714_CR26","doi-asserted-by":"publisher","unstructured":"Tyagi M, Prabhakar AP, Kalra DK. Arterial calcification as an imaging biomarker of the risk of stroke, dementia, and cognitive decline. Prog Cardiovasc Dis. 2026. https:\/\/doi.org\/10.1016\/j.pcad.2026.02.004.","DOI":"10.1016\/j.pcad.2026.02.004"},{"key":"2714_CR27","doi-asserted-by":"publisher","first-page":"e2513812","DOI":"10.1001\/jamanetworkopen.2025.13812","volume":"8","author":"SR Garrison","year":"2025","unstructured":"Garrison SR, Youngson ERE, Perry DA, Campbell FN, Korownyk CS, Green LA, et al. Bedtime vs morning antihypertensive medications in frail older adults: the BedMed-Frail randomized clinical trial. JAMA Netw Open. 2025;8:e2513812.","journal-title":"JAMA Netw Open"},{"key":"2714_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-98267-7","volume":"15","author":"S Zhu","year":"2025","unstructured":"Zhu S, Bo J, Xia T, Gu X. Temporal patterns of cognitive decline after hypertension onset among middle-aged and older adults in China. Sci Rep. 2025;15:16300.","journal-title":"Sci Rep"},{"key":"2714_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70074","volume":"11","author":"Y Shang","year":"2025","unstructured":"Shang Y, Torrandell-Haro G, Vitali F, Brinton RD, Alzheimer\u2019s Disease Neuroimaging I. Combination therapy targeting Alzheimer\u2019s disease risk factors is associated with a significant delay in Alzheimer\u2019s disease-related cognitive decline. Alzheimer's Dement. 2025;11:e70074.","journal-title":"Alzheimer's Dement"},{"key":"2714_CR30","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213441","volume":"104","author":"W Cai","year":"2025","unstructured":"Cai W, Neitzel J, Glodzik L, Blacker D, Ma Y. Effect Modifiers of the association of blood pressure with brain amyloid and tau pathology. Neurology. 2025;104:e213441.","journal-title":"Neurology"},{"key":"2714_CR31","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/ana.27204","volume":"97","author":"M Keum","year":"2025","unstructured":"Keum M, Byun MS, Yi D, Ahn H, Jung G, Jung JH, et al. The use of antihypertensive medication and in vivo Alzheimer\u2019s disease pathology. Ann Neurol. 2025;97:1051\u201361.","journal-title":"Ann Neurol"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02714-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:09:23Z","timestamp":1785881363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02714-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2714"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02714-5","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"31 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}